Keros Therapeutics (KROS) FCF Margin (2019 - 2025)
Keros Therapeutics (KROS) posted FCF Margin of 15339.36% for Q4 2025, down 47936.86% on a QoQ basis from 32.07% in Q3 2025, and down 1381744.0% year-over-year from N/an in Q4 2024.
Keros Therapeutics (KROS) FCF Margin (2019 - 2025) Analysis & Trends
Keros Therapeutics' FCF Margin history runs 6 years deep, the most recent figure standing at 15339.36% for Q4 2025.
- Quarterly FCF Margin fell 1381744.0% year-over-year to 15339.36% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 43.47% (up 467769.0% YoY) and the FY2025 annual result came in at 43.45%, up 462936.0% from the prior year.
- FCF Margin was 15339.36% for Q4 2025 at Keros Therapeutics, down from 32.07% in the prior quarter.
- Across five years, FCF Margin topped out at 76.03% in Q1 2025 and bottomed at 431650.0% in Q3 2023.
- A 5-year average of 45518.48% and a median of 4741.12% in 2024 frame the typical range for FCF Margin.
- Annual changes were most pronounced in 2024 — FCF Margin jumped 42368969 bps — and 2025, when it plunged 1381744 bps.
- Keros Therapeutics' FCF Margin stood at 110.19% in 2021, then surged by 92 bps to 8.41% in 2022, then slumped by 216064 bps to 18181.82% in 2023, then jumped by 92 bps to 1521.93% in 2024, then sank by 908 bps to 15339.36% in 2025.
- Business Quant data shows KROS's FCF Margin at 15339.36% in Q4 2025, 32.07% in Q3 2025, and 167.01% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 10.45% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 43.35% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 23.53% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Keros Therapeutics | 374.82 Mn | 87.42 Mn | - | -15,339.36% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -15,339.36% |
| Sep 30, 2025 | 32.07% |
| Jun 30, 2025 | -167.01% |
| Mar 31, 2025 | 76.03% |
| Dec 31, 2024 | -1,521.93% |
| Sep 30, 2024 | -7,960.31% |
| Mar 31, 2024 | -53,963.86% |
| Dec 31, 2023 | -18,181.82% |
| Sep 30, 2023 | -431,650.00% |
| Mar 31, 2022 | -8.41% |
| Dec 31, 2021 | -110.19% |
| Jun 30, 2021 | -17,427.00% |
| Dec 31, 2019 | -220.64% |
| Sep 30, 2019 | -121.48% |
| Jun 30, 2019 | -208.12% |
| Mar 31, 2019 | -100.52% |